Project Details
Description
I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-directed, adaptive sequential treatment to optimize breast cancer outcomes
| Status | Finished |
|---|---|
| Effective start/end date | 9/8/17 → 6/30/23 |
Funding
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- NATIONAL INSTITUTES OF HEALTH (NIH)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.